Published in J Acquir Immune Defic Syndr on March 01, 2001
Decreased bone mineral density and increased fracture risk in aging men with or at risk for HIV infection. AIDS (2007) 1.95
Body mass index and risk of tuberculosis and death. AIDS (2010) 1.71
Risk of breast, ovary, and uterine corpus cancers among 85,268 women with AIDS. Br J Cancer (2006) 1.53
An optimal body mass index range associated with improved immune reconstitution among HIV-infected adults initiating antiretroviral therapy. Clin Infect Dis (2011) 1.16
Drug use and other risk factors related to lower body mass index among HIV-infected individuals. Drug Alcohol Depend (2008) 1.13
Impact of weight on immune cell counts among HIV-infected persons. Clin Vaccine Immunol (2011) 0.92
Body mass index, immune status, and virological control in HIV-infected men who have sex with men. J Int Assoc Provid AIDS Care (2013) 0.89
Hepatitis C virus infection is associated with insulin resistance among older adults with or at risk of HIV infection. AIDS (2007) 0.87
Higher Time-Updated Body Mass Index: Association With Improved CD4+ Cell Recovery on HIV Treatment. J Acquir Immune Defic Syndr (2016) 0.85
Changes in Body Mass Index Following HAART Initiation among HIV-Infected Women in the Women's Interagency HIV Study. J AIDS Clin Res (2014) 0.82
Relationship between Body Mass Index and Mortality in HIV-Infected HAART Users in the Women's Interagency HIV Study. PLoS One (2015) 0.79
Prevalence and Risk Factors for Overweight and Obesity among HIV-Infected Adults in Dar es Salaam, Tanzania. J Int Assoc Provid AIDS Care (2014) 0.78
Metabolic and anthropometric parameters contribute to ART-mediated CD4+ T cell recovery in HIV-1-infected individuals: an observational study. J Int AIDS Soc (2011) 0.78
Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med (1998) 11.61
A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med (1989) 10.98
Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst (1995) 6.24
Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome. N Engl J Med (1984) 6.11
Association of Streptococcus bovis with carcinoma of the colon. N Engl J Med (1977) 5.86
PCR detection of human papillomavirus: comparison between MY09/MY11 and GP5+/GP6+ primer systems. J Clin Microbiol (1997) 5.76
Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self-report and electronic monitoring. Clin Infect Dis (2001) 5.43
Risk factors for human immunodeficiency virus infection in intravenous drug users. N Engl J Med (1989) 4.72
Transmission of the human immunodeficiency virus. N Engl J Med (1987) 4.17
Immunodeficiency in female sexual partners of men with the acquired immunodeficiency syndrome. N Engl J Med (1983) 3.67
Resistance to experimental autoimmune encephalomyelitis in mice lacking the CC chemokine receptor (CCR)2. J Exp Med (2000) 3.15
Effect of Mycobacterium tuberculosis on HIV replication. Role of immune activation. J Immunol (1996) 2.86
Intravenous drug abusers and the acquired immunodeficiency syndrome (AIDS). Demographic, drug use, and needle-sharing patterns. Arch Intern Med (1985) 2.62
Prevalence, incidence, and type-specific persistence of human papillomavirus in human immunodeficiency virus (HIV)-positive and HIV-negative women. J Infect Dis (2001) 2.51
Knowledge of HIV antibody status and decisions to continue or terminate pregnancy among intravenous drug users. JAMA (1989) 2.41
Lack of transmission of HTLV-III/LAV infection to household contacts of patients with AIDS or AIDS-related complex with oral candidiasis. N Engl J Med (1986) 2.40
Clinical manifestations and predictors of disease progression in drug users with human immunodeficiency virus infection. N Engl J Med (1992) 2.36
The deamination of cytidine and cytosine by acidic buffer solutions. Mutagenic implications. Biochemistry (1966) 2.30
Survival differences in patients with AIDS. J Acquir Immune Defic Syndr (1991) 2.23
Urinary estrogen metabolites and breast cancer: a case-control study. Cancer Epidemiol Biomarkers Prev (1997) 2.23
Ephrin-B reverse signaling is mediated by a novel PDZ-RGS protein and selectively inhibits G protein-coupled chemoattraction. Cell (2001) 2.20
High risk of active tuberculosis in HIV-infected drug users with cutaneous anergy. JAMA (1992) 2.19
Streptococcus bovis septicemia and carcinoma of the colon. Ann Intern Med (1979) 2.06
Effects of HIV infection on the serologic manifestations and response to treatment of syphilis in intravenous drug users. Ann Intern Med (1993) 1.92
Multicenter evaluation of hepatitis C RNA levels among female injection drug users. J Infect Dis (2001) 1.77
Increased risk of bacterial pneumonia in HIV-infected intravenous drug users without AIDS. AIDS (1988) 1.75
Change in depression as a precursor of cardiovascular events. SHEP Cooperative Research Group (Systoloc Hypertension in the elderly). Arch Intern Med (1996) 1.72
Prevalence of lower genital tract infections among human immunodeficiency virus (HIV)-seropositive and high-risk HIV-seronegative women. HIV Epidemiology Research Study Group. Clin Infect Dis (1999) 1.69
Prospective study of human immunodeficiency virus infection and pregnancy outcomes in intravenous drug users. JAMA (1989) 1.63
Altered body composition and increased frequency of diverse malignancies in insulin-like growth factor-II transgenic mice. J Biol Chem (1994) 1.63
The complete hrp gene cluster of Pseudomonas syringae pv. syringae 61 includes two blocks of genes required for harpinPss secretion that are arranged colinearly with Yersinia ysc homologs. Mol Plant Microbe Interact (1995) 1.63
Factors associated with unrecognized HIV-1 infection in an inner-city emergency department. Ann Emerg Med (1996) 1.54
The role of tobacco, alcohol use, and body mass index in oral and pharyngeal cancer. Int J Epidemiol (1994) 1.54
A prospective study of HIV disease progression in female and male drug users. AIDS (1999) 1.54
Longitudinal analysis of bacterial vaginosis: findings from the HIV epidemiology research study. Obstet Gynecol (2001) 1.51
An international collaborative study of the effects of coinfection with human T-lymphotropic virus type II on human immunodeficiency virus type 1 disease progression in injection drug users. J Infect Dis (1996) 1.51
Contrasting effects of identical nutrients given parenterally or enterally after 70% hepatectomy: bacterial translocation. Nutrition (1997) 1.50
Genome-wide association study of bipolar I disorder in the Han Chinese population. Mol Psychiatry (2010) 1.49
Prevalence of cutaneous disease in patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related complex. J Am Acad Dermatol (1987) 1.47
Lack of association of induration size with HIV infection among drug users reacting to tuberculin. Am J Respir Crit Care Med (1996) 1.47
Identification of a red pigment from Streptomyces coelicolor A3(2) as a mixture of prodigiosin derivatives. J Antibiot (Tokyo) (1985) 1.41
Activities of antifolate, antiviral, and other drugs in an immunosuppressed rat model of Pneumocystis carinii pneumonia. Antimicrob Agents Chemother (1992) 1.40
Heroin use during methadone maintenance treatment: the importance of methadone dose and cocaine use. Am J Public Health (1995) 1.40
High risk of human papillomavirus infection and cervical squamous intraepithelial lesions among women with symptomatic human immunodeficiency virus infection. Am J Obstet Gynecol (1991) 1.39
Cervical cytologic abnormalities and papillomavirus in women infected with human immunodeficiency virus. J Acquir Immune Defic Syndr (1990) 1.36
Sustained attention deficit and schizotypal personality features in nonpsychotic relatives of schizophrenic patients. Am J Psychiatry (1998) 1.31
Viral hepatitis-associated intrahepatic cholangiocarcinoma shares common disease processes with hepatocellular carcinoma. Br J Cancer (2009) 1.31
Antibiotic activity in vitro against methicillin-resistant Staphylococcus epidermidis and therapy of an experimental infection. Antimicrob Agents Chemother (1979) 1.30
The treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. Arch Intern Med (1985) 1.29
Phase II study of weekly oxaliplatin and 24-h infusion of high-dose 5-fluorouracil and folinic acid in the treatment of advanced gastric cancer. Br J Cancer (2004) 1.27
Randomly amplified polymorphic DNA analysis of Xylella fastidiosa Pierce's disease and oak leaf scorch pathotypes. Appl Environ Microbiol (1995) 1.27
Emodin, a protein tyrosine kinase inhibitor from Polygonum cuspidatum. J Nat Prod (1992) 1.24
Cancer incidence in women with or at risk for HIV. Int J Cancer (2001) 1.23
Oral findings in patients with acquired immunodeficiency syndrome. Oral Surg Oral Med Oral Pathol (1987) 1.23
Infectious diarrhea in patients with AIDS. Dig Dis Sci (1988) 1.22
Spiroplasmas: cultivation in chemically defined medium. Science (1982) 1.21
Biosynthesis of the antibiotic actinorhodin. Analysis of blocked mutants of Streptomyces coelicolor. J Antibiot (Tokyo) (1987) 1.18
A multicenter study of bacterial vaginosis in women with or at risk for human immunodeficiency virus infection. Infect Dis Obstet Gynecol (2001) 1.17
Apoptosis leads to photoreceptor degeneration in inherited retinal dystrophy of RCS rats. Invest Ophthalmol Vis Sci (1994) 1.17
Comparison of the InPouch TV culture system and Diamond's modified medium for detection of Trichomonas vaginalis. J Clin Microbiol (1997) 1.16
Age and sex effects on HbA1c. A study in a healthy Chinese population. Diabetes Care (1997) 1.12
A prospective study of tuberculosis and human immunodeficiency virus infection: clinical manifestations and factors associated with survival. Clin Infect Dis (1997) 1.11
Biological action of inosine analogs in Leishmania and Trypanosoma spp. Antimicrob Agents Chemother (1984) 1.11
High testicular salvage rate in torsion of the spermatic cord. J Urol (1982) 1.11
Prevalence and risk factors of diabetic retinopathy among noninsulin-dependent diabetic subjects. Am J Ophthalmol (1992) 1.11
Community-acquired opportunistic infections and defective cellular immunity in heterosexual drug abusers and homosexual men. Am J Med (1983) 1.10
Kinase inhibitors from Polygonum cuspidatum. J Nat Prod (1993) 1.10
Management of hemangioma of infancy: review of 245 patients. Plast Reconstr Surg (1997) 1.10
Reactions of cytosine derivatives with acidic buffer solutions. II. Studies on transamination, deamination, and deuterium exchange. Biochemistry (1967) 1.08
Evidence for direct electron transfer by a gram-positive bacterium isolated from a microbial fuel cell. Appl Environ Microbiol (2011) 1.07
Plasma glucose-lowering effect of tramadol in streptozotocin-induced diabetic rats. Diabetes (2001) 1.07
Blood-borne and sexual transmission of human herpesvirus 8 in women with or at risk for human immunodeficiency virus infection. N Engl J Med (2001) 1.06
Lack of association of Streptococcus bovis with noncolonic gastrointestinal carcinoma. Am J Gastroenterol (1987) 1.06
A population-based study of the prevalence and associated factors of diabetes mellitus in southern Taiwan. Diabet Med (1998) 1.06
"Hangman" porphyrins for the assembly of a model heme water channel. J Am Chem Soc (2001) 1.05
Nutritional requirements of two flower spiroplasmas and honeybee spiroplasma. J Bacteriol (1983) 1.05
Nucleosides. 73. Ribosyl analogs of chloramphenicol. J Org Chem (1971) 1.05
The risk of pericardiocentesis. Am J Cardiol (1979) 1.05
Pneumocystis carinii pneumonia therapy with 9-deazainosine in rats. Diagn Microbiol Infect Dis (1987) 1.05
The use of severe combined immunodeficiency mice to study the metabolism of human immunoglobulin G. Cancer (1994) 1.05
Natural products as a source of potential cancer chemotherapeutic and chemopreventive agents. J Nat Prod (1990) 1.03
Oral vanadyl sulfate improves hepatic and peripheral insulin sensitivity in patients with non-insulin-dependent diabetes mellitus. J Clin Invest (1995) 1.03
Cucurbitacin B and isocucurbitacin B: cytotoxic components of Helicteres isora. J Nat Prod (1985) 1.03
Risk of genital human papillomavirus infection in women with human immunodeficiency virus-induced immunosuppression. Int J Cancer (1994) 1.03
Identification of heterogeneous nuclear ribonucleoprotein K (hnRNP K) as a repressor of C/EBPbeta-mediated gene activation. J Biol Chem (1998) 1.03
Double-stranded linear duck hepatitis B virus (DHBV) stably integrates at a higher frequency than wild-type DHBV in LMH chicken hepatoma cells. J Virol (1999) 1.03
An effective hospital-based pneumococcal immunization program. Arch Intern Med (1986) 1.02
Antiproliferative activity of gossypol and gossypolone on human breast cancer cells. Life Sci (1995) 1.02
Significance of urinary epidermal growth factor and its receptor expression in human bladder cancer. Anticancer Res (1997) 1.02
Suppressed transformation and induced differentiation of HER-2/neu-overexpressing breast cancer cells by emodin. Cancer Res (1995) 1.02
A prospective study of syphilis and HIV infection among injection drug users receiving methadone in the Bronx, NY. Am J Public Health (1996) 1.02
Identification and characterization of a nucleolar phosphoprotein, Nopp140, as a transcription factor. Mol Cell Biol (1997) 1.01
Human papillomavirus-associated cervical cytologic abnormalities among women with or at risk of infection with human immunodeficiency virus. Am J Obstet Gynecol (2001) 1.01
A prospective study of tuberculosis and HIV disease progression. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 1.01
Mycobacterium gordonae in the acquired immunodeficiency syndrome. Ann Intern Med (1984) 1.00
Activity of inosine analogs against Pneumocystis carinii in culture. Antimicrob Agents Chemother (1986) 1.00
Mucosal candidal colonization and candidiasis in women with or at risk for human immunodeficiency virus infection. HIV Epidemiology Research Study (HERS) Group. Clin Infect Dis (1998) 1.00